Search

Your search keyword '"Pareo, R."' showing total 6 results
Start Over Author "Pareo, R."
6 results on '"Pareo, R."'

1. Comparison between tadalafil 5 mg vs. Serenoa repens/selenium/lycopene for the treatment of benign prostatic lower urinary tract symptoms secondary to benign prostatic hyperplasia. A phase IV, randomized, multicenter, non-inferiority clinical study. SPRITE study

Author

Morgia, G., primary, Vespasiani, G., additional, Reale, G., additional, Di Mauro, M., additional, Pareo, R., additional, Voce, S., additional, Madonia, M., additional, Fedelini, P., additional, Veneziano, P., additional, Carini, M., additional, Salvia, G., additional, Santaniello, F., additional, Ginepri, A., additional, Bitelli, M., additional, Terrone, C., additional, Gentile, M., additional, Giannantoni, A., additional, Blefari, F., additional, Beatrici, V., additional, Polledro, P., additional, La Rosa, P., additional, Arnone, S., additional, Santelli, G., additional, and Russo, G.I., additional

Published
2017
Full Text
View/download PDF

2. SERENOA REPENS, LICOPENE E SELENIUM VS. TAMSULOSINA PER IL TRATTAMENTO DEI LUTS: UNO STUDIO ITALIANO MULTICENTRICO RANDOMIZZATO COMPARATIVO TRA LA MONOTERAPIA O LA COMBINAZIONE (PROCOMB STUDY)

Author

Morgia, G., Russo, G., Voce, S., Palmieri, F., Gentile, M., Giannantoni, A., Blefari, F., Carini, M., Minervini, A., Ginepri, A., Salvia, G., Vespasiani, G., Cimino, S., Allegro, R., Collura, Z., Fragalà, E., Arnone, S., and Pareo, R.

Subjects
SERENOA REPENS, LICOPENE E SELENIUM ,TAMSULOSINA , LUTS:, PROCOMB STUDY
Published
2014

3. Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study

Author

Ferdinando, Fusco, Riccardo, Sicuteri, Andrea, Rossi, Stathis, Kontodimas, Jose Maria Haro, Ciro, Imbimbo, Mirone, V., Italian Edos Study Group, Aiello, A., Amici, A., Aragona, F., Aragona, C., Artibani, W., Austoni, E., Avolio, A., Bellastella, A., Bonifacio, Vincenzo, Bono, A., Boscaro, M., Bozzo, W., Brausi, M., Breda, G., Caggiano, S., Calabro, A., Calatola, P., Canovaro, G., Caraceni, E., Carani, C., Casarico, A., Castiglioni, M., Ciambrone, G., Cicalese, V., Confortin, L., Conti, G., D'Agata, R., Dal Bianco, M., De Grande, G., Di Ceglie, F., Di Lena, S., Di Santo, V., D'Ottavio, G., Enria, T., Fantaccione, P., Fasolis, G., Foglini, P., Foresta, C., Forti, G., Francavilla, S., Frea, B., Gasparella, V., Gattuccio, F., Gentile, L., Gentile, V., Ghigo, E., Giannini, F., Guarasci, M., Guazzoni, G., Ippoliti, G. B., Jacobellis, U., Jannini, E., La Rocca, L., Lanzafame, F., Laudi, M., Laurenti, C., Leidi, G., Lenzi, A., Leoni, S., Lombardi, G., Lotti, T., Luciani, L., Luciano, M., Ludovico, G., Lunghi, F., Mancini, P., Manganelli, A., Manservigi, D., Mantero, F., Marin, A., Masala, A., Menchini Fabris, F., Miano, L., Monica, B., Montevecchi, R., Montorsi, F., Morrone, G., Motta, M., Muzzonigro, G., Nicita, G., Oliva, G., Pagano, S., Pagliarulo, A., Paola, Q., Paolini, R., Pareo, R. M., Pavone, C., Pecoraro, G., Pinchera, A., Pino, P., Pinzi, N., Pirozzi Farina, F., Pittaluga, P., Pizzocaro, A., Rago, R., Rizzo, M., Romanelli, F., Rovereto, B., Ruggeri, M., Salzano, L., Sanserverino, R., Savoca, G., Scarano, P., Scardapane, R., Scarpa, R., Selvaggi, F. P., Severini, G., Soli, M., Spera, G., Tengalia, R., Testa, G., Tracia, A., Traficante, A., Turriziani, M., Usai, E., Vaccarella, G., Valenti, P., Villanova, A., Vicentini, C., Vincenti, L., Vita, A., Volpi, R., Zambelli, S., and Zito, A.

Subjects
Adult, Male, medicine.medical_specialty, Sildenafil, Phosphodiesterase Inhibitors, Urology, MEDLINE, Carbolines, Erectile Dysfunction, Imidazoles, Patient Satisfaction, Phosphodiesterase Inhibitors, Piperazines, Lower risk, Sildenafil Citrate, Piperazines, Tadalafil, chemistry.chemical_compound, Patient satisfaction, Vardenafil Dihydrochloride, Erectile Dysfunction, prospective multicentric study, medicine, Humans, Sulfones, Practice Patterns, Physicians', PDE5 inhibitors, Aged, Aged, 80 and over, business.industry, Triazines, Imidazoles, General Medicine, Middle Aged, medicine.disease, Erectile dysfunction, Treatment Outcome, chemistry, Vardenafil, Purines, Patient Satisfaction, Physical therapy, Observational study, Original Article, business, medicine.drug, Carbolines
Abstract

The Erectile Dysfunction Observational Study (EDOS) is a 6-months observational prospective multicentric study enrolling men with erectile dysfunction (ED) who asked, to be started on a treatment or to change a previous treatment. Aims of the study were to analyse the pattern of treatment and compare the efficacy of treatments used. Patients were enrolled during a normal hospital visit and were prescribed a treatment for ED. They were asked at baseline and after 3 and 6 months, to answer a set of questions from the International Index of Erectile Function, Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) and Short Form of the Psychological and Interpersonal Relationships Scale questionnaires (SF-PAIRS). Clinicians were free to prescribe any therapy for ED available in the market, and to change therapy at any time during the study. Out of 1 338 patients, available for analysis at 6 months, 624 (47%) changed their treatment during the study and 714 (53%) continued with the drug prescribed at baseline. Patients assuming tadalafil had a significantly higher probability of maintaining the same treatment compared to sildenafil or vardenafil. There was no clinically significant difference in terms of efficacy, patient satisfaction, self-confidence and spontaneity between the different inhibitors of PDE5. The 'time concerns' domain score of SF-PAIRS, was statistically better in patients assuming tadalafil. In conclusion sildenafil, vardenafil and tadalafil show similar efficacy in the clinical practice. However, patients receiving tadalafil display a lower risk to discontinue or change the treatment.

Published
2009

4. 535 - Comparison between tadalafil 5 mg vs. Serenoa repens/selenium/lycopene for the treatment of benign prostatic lower urinary tract symptoms secondary to benign prostatic hyperplasia. A phase IV, randomized, multicenter, non-inferiority clinical study. SPRITE study

Author

Morgia, G., Vespasiani, G., Reale, G., Di Mauro, M., Pareo, R., Voce, S., Madonia, M., Fedelini, P., Veneziano, P., Carini, M., Salvia, G., Santaniello, F., Ginepri, A., Bitelli, M., Terrone, C., Gentile, M., Giannantoni, A., Blefari, F., Beatrici, V., Polledro, P., La Rosa, P., Arnone, S., Santelli, G., and Russo, G.I.

Published
2017
Full Text
View/download PDF

5. [Hypospadias: complications and adult sequalae].

Author

Ciaraldi F, Pareo RM, Quattropanetti R, and Quattropanetti S

Subjects
Adult, Aged, Humans, Hypospadias pathology, Hypospadias surgery, Male, Middle Aged, Hypospadias complications
Abstract

Hypospadia is a very frequent urogenital malformation. The authors consider the immediate disorders, the outcomes and the involvements in the adults and in the elders to the attempts of surgical regress.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results